Explore UK companies developing stem cell and iPSC technologies, therapies and research tools.
Human iPSC platform for neurodegenerative disease drug discovery
Talisman Therapeutics is a drug discovery company specialising in human induced pluripotent stem cell (iPSC) models of neurodegenerative disease. The company operates both an…
Automated single-cell isolation and cloning instruments for cell biology
Iota Sciences is a developer of automated single-cell handling instruments and cell-line engineering services. The company's platform automates single-cell isolation and cloning…
High-throughput iPSC reprogramming and stem cell drug discovery services
Oxford StemTech is a contract research company providing induced pluripotent stem cell (iPSC) reprogramming and drug discovery services using its proprietary platform. The…
Human iPSC-derived cells and services for drug discovery research
Axol Bioscience is a biotechnology company manufacturing and supplying human induced pluripotent stem cell-derived cells and outsourced laboratory services for drug discovery and…
Combinatorial stem cell screening platform for therapy development
Plasticell is a biotechnology company developing cell and gene therapies and enabling drug discovery through its proprietary platform. The technology uses bead-based combinatorial…
Automated robotic systems for cell therapy and stem cell manufacture
Sakarta is an instruments and equipment company developing automated robotic solutions for cell therapy and stem cell manufacturing. Working with partners in the UK and Japan, it…
Ex vivo haematopoietic stem cell gene therapies for rare genetic diseases
Orchard Therapeutics is a gene therapy company developing ex vivo haematopoietic stem cell therapies for rare genetic diseases, primarily severe neurometabolic and immunological…
Automated bioreactor platform for GMP cell therapy manufacturing
Aglaris is a developer of automated cell manufacturing systems for advanced therapy medicinal products. Its flagship platform integrates real-time process monitoring, single-use…
Precision-programmed human iPSC-derived cells for biomedical research
bit.bio is a Cambridge-based synthetic biology company that programmes human induced pluripotent stem cells into defined, mature cell types for use in pharmaceutical and academic…
Rejuvenation biology company decoding the genomics of cellular ageing reversal
clock.health is a biotechnology company developing therapies to reverse cellular ageing and extend healthspan by decoding the biological programmes that govern cell rejuvenation.…
Cell and gene therapy CDMO with clinical and commercial manufacturing
RoslinCT is a CDMO specialising in advanced cell and gene therapies. Operating purpose-built cGMP facilities at Edinburgh BioQuarter and in Hopkinton, Massachusetts, it provides…
AI-native platform for cell culture process design and optimisation
Tolemy Bio Ltd is a company developing an AI-native platform for cell therapy process development and manufacturing optimisation. The platform ingests experimental and bioreactor…